Goodbye March, Hello April

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Goodbye March, Hello April

in response to

Re: 2019 Potential Events

BearDownAZ

posted on Mar 22, 2019 06:52PM

Closing out March and starting April with a few events:

BIO-Europe Spring March 25-27, 2019; Vienna, Austria (Resverlogix and Zenith both listed as presenting companies). Resverlogix at 10:15 AM on Tuesday March 26 and Zenith at 11AM on Wednesday March 27. Local time, so wee hours of the pre-market morning here in US/Canada.

14th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2019): March 26-31, 2019; Lisbon, Portugal (Resverlogix on schedule with 2 abstract, see abstracts here). Great timing with Biogen/Eisai shuttering their aducanumab trial.

American Association for Cancer Research (AACR) March 29 to April 3, 2019. Zenith presenting a poster (see here) on Monday April 1. Hopefully a well received ZEN-3694/mCRPC trial presentation. Shouldn't be long until the ZEN-3694/TNBC trial with Pfizer's PARP inhibitor kicks off.